Enhancer Role of STAT5 in CD2 Activation of IFN-γ Gene Expression
Rivkah Gonsky, Richard L. Deem, Jay Bream, Howard A. Young and Stephan R. Targan
J Immunol November 15, 2004, 173 (10) 6241-6247; DOI: https://doi.org/10.4049/jimmunol.173.10.6241
Rivkah Gonsky
*Inflammatory Bowel Disease Research Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048;
Richard L. Deem
*Inflammatory Bowel Disease Research Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048;
Jay Bream
† Lymphocyte Cell Biology Section, Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases Intramural Research Program, National Institutes of Health, Bethesda, MD 20892; and
Howard A. Young
‡ Cellular and Molecular Immunology Section, Laboratory of Experimental Immunology, National Cancer Institute, Frederick, MD 21702
Stephan R. Targan
*Inflammatory Bowel Disease Research Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048;
In this issue
Enhancer Role of STAT5 in CD2 Activation of IFN-γ Gene Expression
Rivkah Gonsky, Richard L. Deem, Jay Bream, Howard A. Young, Stephan R. Targan
The Journal of Immunology November 15, 2004, 173 (10) 6241-6247; DOI: 10.4049/jimmunol.173.10.6241